Effects of Atorvastatin and Fluvastatin on plasma glucose levels in type 2 diabetes patients with respect to their anti-hyperlipidemia actions

被引：0
|
作者：
Okayama, N
Imaeda, K
Akao, M
Imai, S
Takeuchi, Y
Yamada, K
Itoh, M
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [31] Effect of glucose control on lipid levels in patients with type 2 diabetes
    Parhofer, KG
    Laubach, E
    Geiss, HC
    Otto, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (18) : 958 - 962
  • [32] Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Patients With Hyperlipidemia Having Coronary Artery Disease
    Kurtoglu, Ertugrul
    Balta, Sevket
    Sincer, Isa
    Altas, Yakup
    Atas, Halil
    Yilmaz, Mucahid
    Korkmaz, Hasan
    Erdem, Kenan
    Akturk, Erdal
    Demirkol, Sait
    Can, Cagdas
    ANGIOLOGY, 2014, 65 (09) : 788 - 793
  • [33] Effect of High β-Glucan Barley on Postprandial Plasma Glucose Levels in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes
    Higa, Mariko
    Hashimoto, Ayana
    Hayasaka, Moe
    Hijikata, Mai
    Ueda, Ayami
    Oda, Kenzaburo
    Kato, Daisuke
    Yamashita, Kaoru
    Ichijo, Takamasa
    DIABETES, 2018, 67
  • [34] Apolipoprotein E is a determinant of PLTP activity in plasma from type 2 diabetes mellitus patients: Effects of atorvastatin treatment
    Dallinga-Thie, GM
    Vantol, A
    DIABETES, 2005, 54 : A1 - A1
  • [35] No impact of oral quercetin on plasma glucose in patients with type 2 diabetes
    St Peter, John V.
    Pirner, Mark A.
    Halstenson, Charles E.
    Brundage, Richard C.
    Khan, Mehmood A.
    FASEB JOURNAL, 2011, 25
  • [36] Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
    Mita, Tomoya
    Nakayama, Shiho
    Abe, Hiroko
    Gosho, Masahiko
    Iida, Hitoshi
    Hirose, Takahisa
    Kawamori, Ryuzo
    Watada, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (03) : 297 - 303
  • [37] Effects of fenofibrate on plasma level of ubiquinol-10 in type 2 Diabetes Mellitus with hyperlipidemia
    Asano, A
    Kobayashi, J
    Murase, Y
    Yamaaki, N
    Yagi, K
    Mabuchi, H
    DIABETES, 2005, 54 : A236 - A236
  • [38] Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
    Gu Weijun
    Lu Juming
    Yang Guoqing
    Dou Jingtao
    Guo Qinghua
    Mu Yiming
    Pan Changyu
    Advances in Therapy, 2008, 25 : 884 - 893
  • [39] Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes
    Nakamura, N
    Yamazaki, K
    Satoh, A
    Urakaze, M
    Kobayashi, M
    Yamabe, H
    Osawa, H
    Shirato, K
    Sugawara, T
    Nakamura, M
    Tamura, M
    Okumura, K
    IN VIVO, 2003, 17 (02): : 177 - 180
  • [40] Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
    Gu Weijun
    Lu Juming
    Yang Guoqing
    Dou Jingtao
    Guo Qinghua
    Mu Yiming
    Pan Changyu
    ADVANCES IN THERAPY, 2008, 25 (09) : 884 - 893
12345